The typical clinical symptoms are associated with dysfunction of the liver and the gastrointestinal tract, such as diarrhea, skin rash, and fever up to 41°C. In addition, severe pancytopenia with bone marrow hypoplasia or aplasia has been reported. A diagnosis of TA-GVHD is established by HLA typing of peripheral blood lymphocytes (PBLs) and fibroblasts or of lymphocytes of both the transfusion recipient and the blood donor. Histologic examination of a skin biopsy confirms the diagnosis.
In this article, we present an alternative method for establishing the diagnosis of TA-GVHD: multilocus DNA fingerprinting. With this method, hypervariable DNAfragment patterns that are distributed throughout the eukaryotic genome are investigated. In principle, several different multilocus probes could be used, such as minisatellites' or synthetic oligonucleotide probes* consisting of simple nucleotide repeats, as both provide an individual-specific banding pattern. However, the oligonucleotide probe (CAC)' and its complementary equivalent (GTG)' are most informative for man and are uncomplicated to handle.
An equivocal diagnosis can be obtained even faster by using a polymerase chain reaction (PCR)-based investigation of hypervariable regions in the genome that show stretches of simple repetitive sequences. In this case, we used the analysis of hypervariable intronic simple repeats in the HLA-DRB genes.
Case Report A 23-year-old woman first presented with left cervical lymph node enlargement in March 1989. In July of the same year, Hodgkin's disease of the lymphocyte-rich type was diagnosed by biopsy. Enlarged lymph nodes were found on both sides of the diaphragm (clinical stage IIIB). Combined chemotherapy was therefore initiated with three cycles of cyclophosphamide, vincristine, procarbazine, and prednisone and of adriamycin, bleomycin, dacarbazine, and vinblastine until January 1990. At that time, a lymph node relapse was observed and a new diagnosis made of Hodgkin's disease of the nodular-sclerosing type. Since March 1990, the patient received total nodal irradiation (40 Gy). This cycle was interrupted several times, because of myelosuppression and subsequent transfusions of nonirradiated but filtered packed red cell transfusions (Sepacell R 500 A, Asahi, Tokyo, J a~a n ) .~ The last packed red cell transfusion was administered on August 1; 7 days later, the patient was hospitalized with an erythematous rash, fever to 41"C, and diarrhea, but no evidence of Hodgkin's relapse. All blood cultures remained negative. Yet Candida albicam and Aspetgillusfumigatus were identified in the lung. Severe pancytopenia was present until the patient's death. Her condition deteriorated in spite of several therapeutic regimens: cyclosporine A, corticosteroids, granulocyte-macrophagecolonystimulating factor to stimulate the stem cells,1o and T-cell receptor antibody @MA 031, Behring, Marburg, Germany) in addition to antibiotics, antimycotics, and antiviral therapy. On September 4, the patient died of general heart and lung failure as a consequence of the fungal sepsis. The diagnosis of TA-GVHD was established on the basis of HLA typing of PBLs: mother, A2/3, B7113, 0~6 1 7 ; father, A1124, Bw441w57, Cw3/-; and patient, A23132, B7/w44, &4/7 (which is identical to the donor of 1 unit of the transfused packed red cells). At autopsy, residual Hodgkin's disease was found in one cervical lymph node.
Materials and Methods
We performed the isolation of DNA from tissue and blood samples with normal WBC counts essentially according to the method of Sambrook and coworkerst1 and the isolation of DNA from hair root cells according to the method of Teifel-Greding et a1.I2 Samples of blood from the patient (WBC counts approx. 400/pL) were incubated at 0°C with RBC-lysis buffer (2.7 mM [2.7 mmoVL] KCI, 137 mM [137 mmoVL] NaCl, 1.5 mM [1.5 mmoVL] KH2P04, 7.75 mM [7. 75 mmolLJ Na2HP04, pH 7.4). Then we suspended the cells in 10 mM (10 mmoVL) Tris-HC1 (pH 8.0), 10 mM (10 mmoVL) EDTA, and 150 mM (150 mmoVL) NaCl, added proteinase K and sodium dodecyl sulfate to a final concentration of 300 p g per mL and 0.6 percent, and incubated the mixture at 37°C. Standard phenol extraction and ethanol precipitation were performed. Afterwards we pelleted the DNA at 20,000 rpm for 45 minutes at 4°C (Beckmann SW41 rotor) and dissolved the DNA in 10 mM (10 mmoVL) Tris-HC1, pH 8.0, and 1 mM (1mmoVL) EDTA.
Up to 10 pg of each DNA sample was digested overnight by using HinfI (5 U/pg DNA) as recommended by the manufacturer (BRL, Eggenstein, Germany). We carried out agarose gel electrophoresis (1 Vlcm, 40 hours), labeling of the oligonucleotide probes (GTG)s (Fresenius AG, Oberursel, Germany) with 32P-ATP (Amersham, Braunschweig, Germany), and hybridization in the gel as described by Schafer et We amplified 1 pg of human genomic DNA by PCR for 30 cycles. The following HLA-DR oligonucleotide primer combinationst4 were used: 1) 0-DRwl1.510-DRBrep annealing at 54°C and 2) 0-DRwll.1010-DRBrep annealing at 50°C. They flank exon 2 of the DRB gene and part of intron 2 containing a simple (gt), (ga), repeat sequence. The amplified DNA was separated on a 1-percent agarose gel to elute the 420-base pair (bp) (ll.lO/rep) and 448-bp (11Jrep) fragment a123 length ranges. We then labeled the isolated DNA with T4 polynucleotide kinase and 32P-ATP,13 separated the labeled DNA fragments on a 5-percent denaturing polyacrylamide gel," and autoradiographed or transferred them onto a nylon membrane (Hybond N, Amersham) by electroblotting. Afterwards the filter was hybridized with the internal HDB oligon~cleotide~~ at 5 9 T , washed throughly, and autoradiographed.
Results
To verify the suspected diagnosis of TA-GVHD, we compared the genetic fingerprint pattern of the PBLs with that obtained from the patient's hair roots. The latter sample exhibited the patient's constitutive banding pattern, while the pattern obtained from the PBLs was entirely different (Fig.  1A) . Consequently, the circulating PBLs are derived from the donor of the transfused packed red cells (see donor lane in Fig.  lb) .
To study the course of the disease, blood samples were taken at least every third day, beginning on Day 9 after the onset of the fever. We found the donor's banding pattern in every blood sample. Only in the first sample, taken on Day 9 after the onset of the fever, did we detect some additional bands (Fig.  1B) . These bands derive from the patient herself. The band patterns are inherited according to Mendelian lawst3 (see parental patterns in Fig. lb) . Two days later and thereafter, the patient's own PBLs can no longer be demonstrated. In a control study, nonfiltered blood was administered to patients who underwent open heart surgery; they did not show symptoms of TA-GVHD. By genetic fingerprinting, no donor white cells After the patient's death, we examined various tissue samples (lung, spleen, skin, and lymph node) by genetic fingerprinting. Bands corresponding to the blood donor's pattern were not observed in any tissue studied (Fig. 2) , which indicated less than 10 percent donor cells. Only the large fragments of skin and lymph node seem to show a difference between the tissues. This is, however, due to an electrophoretic artifact resulting from different salt concentrations in the two samples.
In addition, we investigated the lengths of the polymorphic simple repeat (gt),(ga), locus in the 2nd intron of the HLA- DRB genes.I4 This analysis confirmed the results obtained from the genetic fingerprints described above. The pattern of the amplified exonhntron fragment obtained from PBLs circulating in the patient differs from that of the other tissues but is identical with that of the blood donor. Even with this very sensitive method, we were unable to identify any DNA fragments originating from the donor in the tissues of the patient (Fig. 3) . These results were confirmed by electroblot hybridizations (Kunstmann E. Unpublished observations, 1992; data not shown).
Discussion
In TA-GVHD, mortality is approximately 90 percent. Several technical and clinical problems make rapid diagnosis of the syndrome difficult. Clinically, single symptoms may be misinterpreted if they are not evaluated in the whole context, as the rarity of the syndrome renders its recognition more delicate, while the rapid progression of the disease makes a complete differential diagnosis difficult. Finally, the diagnosis of TA-GVHD by HLA typing is not always possible, for example, if the amount of PBLs is too low.
The examination of multilocus fingerprints via simple repetitive sequences in the genome is an alternative to the use of conventional HLA typing to make a diagnosis of TA-GVHD. With this method, any two individuals, with the exception of monozygotic twins, can be discriminated with virtual certainty. Thus, a diagnosis of TA-GVHD must be suspected if the specific banding pattern obtained from circulating PBLs differs from that obtained from tissue cells (e.g., hair root cells).
This As an alternative to genetic fingerprinting, we were able to identify donor DNA by determining the variability in length in the 2nd intron of the HLA-DRB genes.
Remarkably, even with this extremely sensitive method, no circulating PBLs derived from the patient were detected.
In principle, one can obtain an indication for the presence of allogenic circulating lymphocytes only 1 day after taking the blood sample. At first, DNA from PBLs is amplified by PCR and analyzed by gel electrophoresis. We routinely purify the bands by elution, label them, and separate the DNA in a denaturing, sequencing gel. This procedure also takes 2 to 3 days but has the advantage of higher sensitivity. The provisional results should be verified by specific hybridization after electroblotting, which is possible 3 days after the beginning of the investigation. Alternatively, hypervariable DNA loci could be amplified, and the variability of these loci can be demonstrated in principle by agarose gel electrophoresis within 1 day of taking the PBLs. In the present case, we were unable to detect invading donor lymphocytes in the host organs, either by genetic fingerprinting (Fig. 2) or with the help of PCR-amplified simple repetitive sequences (Fig. 3) . This means that there was less than 0.1 percent donor cells in the patient's tissues, an amount not detectable in one round of PCR without separation of the different targets." We purposely avoided selective or exclusive amplification of donor alleles in order to generate comparative data.
It is mandatory to prevent TA-GVHD. The prognosis is fatal in most cases and no therapeutic regimen has yet been successful. Irradiation of blood components is not always practicable because of the availibility of irradiators at each organization and high costs.'* But, contrary to expectations, white cell reduction in blood components by filtration is obviously not a sufficient prevention, as exemplified by the reported case here.
